Ocular Therapeutix™ to Present at the Jefferies 2019 London Healthcare Conference
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Donald Notman, Chief Financial Officer of Ocular Therapeutix, will give a company presentation on Thursday, November 21st at 8:40 a.m. GMT at the Jefferies 2019 London Healthcare Conference being held at the Waldorf Hilton in London, UK. In addition